Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.7140
+0.0030 (0.42%)
Aug 3, 2026, 12:42 PM CET
Transgene Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7.21 | 6.35 | 7.9 | 10.34 | 17.41 | |
Revenue Growth | 13.49% | -19.58% | -23.63% | -40.60% | 75.62% |
Gross Profit | 7.21 | 6.35 | 7.9 | 10.34 | 17.41 |
Selling, General & Admin | 7.31 | 7.76 | 6.99 | 7.91 | 7.37 |
Research & Development | 33.9 | 34.28 | 29.59 | 32.17 | 32.88 |
Other Operating Expenses | 1.06 | -0.03 | 1.37 | 0.17 | 0.69 |
Total Operating Expenses | 42.27 | 42.01 | 37.95 | 40.25 | 40.94 |
Operating Income | -35.06 | -35.66 | -30.05 | -29.9 | -23.53 |
Interest Income | - | - | 7.72 | -2.9 | 3.99 |
Other Non-Operating Income (Expense) | -2.47 | 1.69 | - | - | - |
Total Non-Operating Income (Expense) | -2.47 | 1.69 | 7.72 | -2.9 | 3.99 |
Pretax Income | -37.52 | -33.97 | -22.33 | -32.8 | -19.54 |
Net Income | -37.52 | -33.97 | -22.33 | -32.8 | -19.54 |
Net Income to Common | -37.52 | -33.97 | -22.33 | -32.8 | -19.54 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 145 | 117 | 101 | 100 | 91 |
Shares Outstanding (Diluted) | 145 | 117 | 101 | 100 | 91 |
Shares Change | 23.88% | 15.98% | 1.09% | 9.21% | 8.67% |
EPS (Basic) | -0.26 | -0.29 | -0.22 | -0.33 | -0.21 |
EPS (Diluted) | -0.26 | -0.29 | -0.22 | -0.33 | -0.21 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -37.89 | -26.61 | -37.34 | -21.8 | -26.58 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.26 | -0.23 | -0.37 | -0.22 | -0.29 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -486.25% | -561.28% | -380.34% | -289.10% | -135.10% |
Profit Margin | -520.44% | -534.72% | -282.63% | -317.13% | -112.19% |
FCF Margin | -525.49% | -418.92% | -472.63% | -210.75% | -152.65% |
EBITDA | -33.73 | -34.38 | -28.48 | -28.22 | -21 |
EBITDA Margin | -467.86% | -541.11% | -360.44% | -272.80% | -120.62% |
EBIT | -35.06 | -35.66 | -30.05 | -29.9 | -23.53 |
EBIT Margin | -486.25% | -561.28% | -380.34% | -289.10% | -135.10% |